SRSF2 and chronic myelomonocytic leukemia: Regarding the phenotype of CMML patients, however, there was an unexpected and consistent finding in both cohorts: in patients with an SRSF2 mutation, the proportion of patients with anemia with Hb < 10 g/dL was lower than among wildtype patients.